Cellosaurus SBC-3/ADM (CVCL_M841)

Cell line name SBC-3/ADM
Accession CVCL_M841
Resource Identification Initiative To cite this cell line use: SBC-3/ADM (RRID:CVCL_M841)
Comments Doubling time: 22 hours (PubMed=3012965).
Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Disease Small cell lung carcinoma (NCIt: C4917)
Derived from metastatic site: Bone marrow.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1678 (SBC-3)
Sex of cell Male
Age at sampling 24Y
Category Cancer cell line
Publications

PubMed=3012965
Miyamoto H.
Establishment and characterization of an adriamycin-resistant subline of human small cell lung cancer cells.
Acta Med. Okayama 40:65-73(1986)

PubMed=3012966
Miyamoto H.
In vitro chemosensitivity and radiosensitivity of an adriamycin-resistant subline of human small cell lung cancer cells.
Acta Med. Okayama 40:75-81(1986)

PubMed=3032107
Kimura I., Ohnoshi T., Hiraki S., Miyamoto H.
Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance.
Gan To Kagaku Ryoho 14:830-836(1987)

PubMed=10628341
Ikubo S., Takigawa N., Ueoka H., Kiura K., Tabata M., Shibayama T., Chikamori M., Aoe K., Matsushita A., Harada M.
In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines.
Anticancer Res. 19:3985-3988(1999)